147 related articles for article (PubMed ID: 10991965)
1. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat.
Nielsen CK; Ross FB; Smith MT
J Pharmacol Exp Ther; 2000 Oct; 295(1):91-9. PubMed ID: 10991965
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antinociceptive effect of oxycodone in male and female rats.
Holtman JR; Wala EP
Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
[TBL] [Abstract][Full Text] [Related]
4. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
5. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
6. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
7. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents.
Stevens CW
Cancer Surv; 1994; 21():25-47. PubMed ID: 8564997
[TBL] [Abstract][Full Text] [Related]
9. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.
Lemberg KK; Siiskonen AO; Kontinen VK; Yli-Kauhaluoma JT; Kalso EA
Anesth Analg; 2008 Feb; 106(2):463-70, table of contents. PubMed ID: 18227301
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological analysis of a morphine/substance P chimeric molecule with full analgesic potency in morphine-tolerant rats.
Kream RM; Liu NL; Zhuang M; Esposito PL; Esposito TR; Stefano GB; Witmeyer JJ
Med Sci Monit; 2007 Feb; 13(2):BR25-31. PubMed ID: 17261977
[TBL] [Abstract][Full Text] [Related]
12. Central administration of selective melanocortin 4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia.
Kalange AS; Kokare DM; Singru PS; Upadhya MA; Chopde CT; Subhedar NK
Brain Res; 2007 Nov; 1181():10-20. PubMed ID: 17915196
[TBL] [Abstract][Full Text] [Related]
13. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II.
Tang L; Shukla PK; Wang LX; Wang ZJ
J Pharmacol Exp Ther; 2006 May; 317(2):901-9. PubMed ID: 16505162
[TBL] [Abstract][Full Text] [Related]
14. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
Cleary J; Mikus G; Somogyi A; Bochner F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1528-34. PubMed ID: 7996467
[TBL] [Abstract][Full Text] [Related]
15. Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice.
Yeşilyurt O; Dogrul A
Neurosci Lett; 2004 Nov; 371(2-3):122-7. PubMed ID: 15519741
[TBL] [Abstract][Full Text] [Related]
16. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.
Ross FB; Smith MT
Pain; 1997 Nov; 73(2):151-157. PubMed ID: 9415500
[TBL] [Abstract][Full Text] [Related]
17. The antinociceptive effect of morphine is reversed by okadaic acid in morphine-naive but not in morphine-tolerant mice.
Ocaña M; Entrena JM; Baeyens JM; Del Pozo E
Pharmacol Biochem Behav; 2007 Jan; 86(1):21-6. PubMed ID: 17234262
[TBL] [Abstract][Full Text] [Related]
18. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
19. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
Smith GD; Smith MT
J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
[TBL] [Abstract][Full Text] [Related]
20. Estrous cycle stage-dependent expression of acute tolerance to morphine analgesia in rats.
Shekunova EV; Bespalov AY
Eur J Pharmacol; 2004 Feb; 486(3):259-64. PubMed ID: 14985047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
